N-methyl-d-aspartate receptor inhibition by an apolipoprotein E-derived peptide relies on low-density lipoprotein receptor-associated protein

Neuropharmacology

Volumn 55, Issue 2, 2008, Pages 204-214

  Sheng, Zhenyu ^a   Prorok, Mary ^a   Brown, Brigid E ^a   Castellino, Francis J ^a  

^a UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

Apolipoprotein E; Conantokins; Electrophysiology; Ion channels; LRP; NMDA receptor subtypes

Indexed keywords

ALPHA 2 MACROGLOBULIN; APOLIPOPROTEIN E; APOLIPOPROTEIN E[133-149]; GLYCINE; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PROTEOHEPARAN SULFATE; RECEPTOR ASSOCIATED PROTEIN; SYNTHETIC PEPTIDE;

ANIMAL CELL; ARTICLE; BINDING COMPETITION; BINDING SITE; BRAIN ELECTROPHYSIOLOGY; CELL STRAIN; CELL SURFACE; CHO CELL; CONTROLLED STUDY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; RECEPTOR BLOCKING; REGULATORY MECHANISM;

ANIMALS; APOLIPOPROTEINS E; BINDING SITES; CELL LINE, TRANSFORMED; CELL MEMBRANE; CRICETINAE; CRICETULUS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; DRUG INTERACTIONS; GLYCINE; HUMANS; LDL-RECEPTOR RELATED PROTEINS; MEMBRANE POTENTIALS; N-METHYLASPARTATE; PATCH-CLAMP TECHNIQUES; PEPTIDE FRAGMENTS; PROTEIN BINDING; RECEPTORS, N-METHYL-D-ASPARTATE; SPERMINE; TRANSFECTION;

EID: 47149104839     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2008.05.016     Document Type: Article

References (61)

1. Aggerbeck L.P., Wetterau J.R., Weisgraber K.H., Wu C.S., and Lindgren F.T. Human apolipoprotein E3 in aqueous solution. II. Properties of the amino- and carboxyl-terminal domains. J. Biol. Chem. 263 (1988) 6249-6258
2. Aono M., Bennett E.R., Kim K.S., Lynch J.R., Myers J., Pearlstein R.D., Warner D.S., and Laskowitz D.T. Protective effect of apolipoprotein E-mimetic peptides on N-methyl-d-aspartate excitotoxicity in primary rat neuronal-glial cell cultures. Neuroscience 116 (2003) 437-445
3. Aono M., Lee Y., Grant E.R., Zivin R.A., Pearlstein R.D., Warner D.S., Bennett E.R., and Laskowitz D.T. Apolipoprotein E protects against NMDA excitotoxicity. Neurobiol. Dis. 11 (2002) 214-220
4. Araneda R.C., Lan J.Y., Zheng X., Zukin R.S., and Bennett M.V.L. Spermine and arcaine block and permeate N-methyl-d-aspartate receptor channels. Biophys. J. 76 (1999) 2899-2911
5. Bacskai B.J., Xia M.Q., Strickland D.K., Rebeck G.W., and Hyman B.T. The endocytic receptor protein LRP also mediates neuronal calcium signaling via N-methyl-d-aspartate receptors. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 11551-11556
6. Battaglia F., Wang H.Y., Ghilardi M.F., Gashi E., Quartarone A., Friedman E., and Nixon R.A. Cortical plasticity in Alzheimer's disease in humans and rodents. Biol. Psychiatry 62 (2007) 1405-1412
7. Benveniste M., and Mayer M.L. Multiple effects of spermine on N-methyl-d-aspartic acid responses of rat cultured hippocampal neurones. J. Physiol. 161 (1993) 131-163
8. Bi H., and Sze C.I. N-methyl-d-aspartate receptor subunit NR2A and NR2B messenger RNA levels are altered in the hippocampus and entorhinal cortex in Alzheimer's disease. J. Neurol. Sci. 200 (2002) 11-18
9. Chatterton J.E., Awobuluyi M., Premkumar L.S., Takahashi H., Talantova M., Shin Y., Ciu J., Tu S., Sevarino K.A., Nakanishi N., Tong G., Lipton S.A., and Zhang D. Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits. Nature 415 (2002) 793-798
10. Charriaut-Marlangue C., Otani S., Creuzet C., Ben-Ari Y., and Loeb J. Rapid activation of hippocampal casein kinase II during long-term potentiation. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 10232-10236
11. Clay M.A., Anantharamaiah G.M., Mistry M.J., Balasubramaniam A., and Harmony J.A. Localization of a domain in apolipoprotein E with both cytostatic and cytotoxic activity. Biochemistry 34 (1995) 11142-11151
12. 2, bind to LRP1. Biochemistry 43 (2004) 7328-7335
13. Dallongeville J., Roy M., Leboeuf N., Xhignesse M., Davignon J., and Lussier-Cacan S. Apolipoprotein E polymorphism association with lipoprotein profile in endogenous hypertriglyceridemia and familial hypercholesterolemia. Arterioscler. Thromb. 11 (1991) 272-278
14. Das S., Sasaki Y.F., Rothe T., Premkumar L.S., Takasu M., Crandall J.E., Dikkes P., Conner D.A., Rayudu P.V., Cheung W., Chen H.S., Lipton S.A., and Nakanishi N. Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A. Nature 393 (1998) 377-381
15. Erreger K., Geballe M.T., Kristensen A., Chen P.E., Hansen K.B., Lee C.J., Yuan H., Le P., Lyuboslavsky P.N., Micale N., Jørgensen L., Clausen R.P., Wyllie D.J., Snyder J.P., and Traynelis S.F. Subunit-specific agonist activity at NR2A-, NR2B-, NR2C-, and NR2D-containing N-methyl-d-aspartate glutamate receptors. Mol. Pharmacol. 72 (2007) 907-920
16. Eugenin E.A., King J.E., Nath A., Calderon T.M., Zukin R.S., Bennett M.V., and Berman J.W. HIV-tat induces formation of an LRP-PSD-95-NMDAR-nNOS complex that promotes apoptosis in neurons and astrocytes. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 3438-3443
17. FitzGerald D.J., Fryling C.M., Zdanovsky A., Saelinger C.B., Kounnas M., Winkles J.A., Strickland D., and Leppla S. Pseudomonas exotoxin-mediated selection yields cells with altered expression of low-density lipoprotein receptor-related protein. J. Cell Biol. 129 (1995) 1533-1541
18. Godyna S., Liau G., Popa I., Stefansson S., and Argraves W.S. Identification of the low density lipoprotein receptor-related protein (LRP) as an endocytic receptor for thrombospondin-1. J. Cell Biol. 129 (1995) 1403-1410
19. Harris-White M.E., and Frautschy S.A. Low density lipoprotein receptor-related proteins (LRPs), Alzheimer's and cognition. Curr. Drug Targets CNS Neurol. Disord. 4 (2005) 469-480
20. Hoe H.S., Pocivavsek A., Chakraborty G., Fu Z., Vicini S., Ehlers M.D., and Rebeck G.W. Apolipoprotein E receptor 2 interactions with N-methyl-d-aspartate receptor. J. Biol. Chem. 281 (2006) 3425-3431
21. Hollmann M., Boulter J., Maron C., Beasley L., Sullivan J., Pecht G., and Heinemann S. Zinc potentiates agonis-induced currents at certain splice variants of the NMDA receptor. Neuron 10 (1993) 943-954
22. Hynd M.R., Scott H.L., and Dodd P.R. Differential expression of N-methyl-d-aspartate receptor NR2 isoforms in Alzheimer's disease. J. Neurochem. 90 (2004) 913-919
23. Innerarity T.L., Friedlander E., Rall S.C., Weisgraber K.H., and Mahley R.W. The receptor-binding domain of human apolipoprotein E. Binding of apolipoprotein E fragments. J. Biol. Chem. 258 (1983) 12341-12347
24. Ji Z.S., Brecht W.J., Miranda R.D., Hussain M.M., Innerarity T.L., and Mahley R.W. Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells. J. Biol. Chem. 268 (1993) 10160-10167
25. Kendrick S.J., Dichter M.A., and Wilcox K.S. Characterization of desensitization in recombinant N-methyl-d-aspartate receptors: comparison with native receptors in cultured hippocampal neurons. Brain Res. Mol. Brain Res. 57 (1998) 10-20
26. Klein R.C., Prorok M., Galdzicki Z., and Castellino F.J. The amino acid residue at sequence position 5 in the conantokin peptides partially governs subunit-selective antagonism of recombinant N-methyl-d-aspartate receptors. J. Biol. Chem. 276 29 (2001) 26860-26867
27. Klein R.C., and Yakel J.L. Inhibition of nicotinic acetylcholine receptors by apolipoprotein E-derived peptides in rat hippocampal slices. Neuroscience 127 (2004) 563-567
28. Lalazar A., Weisgraber K.H., Rall Jr. S.C., Giladi H., Innerarity T.L., Levanon A.Z., Boyles J.K., Amit B., Gorecki M., Mahley R.W., and Vogel T. Site-specific mutagenesis of human apolipoprotein E. Receptor binding activity of variants with single amino acid substitutions. J. Biol. Chem. 263 (1988) 3542-3545
29. Laurie D.J., and Seeburg P.H. Ligand affinities at recombinant N-methyl-d-aspartate receptors depend on subunit composition. Eur. J. Pharmacol. 268 (1994) 335-345
30. Lee Y., Aono M., Laskowitz D., Warner D.S., and Pearlstein R.D. Apolipoprotein E protects against oxidative stress in mixed neuronal-glial cell cultures by reducing glutamate toxicity. Neurochem. Int. 44 (2004) 107-118
31. Madry C., Mesic I., Bartholomäus I., Nicke A., Betz H., and Laube B. Principal role of NR3 subunits in NR1/NR3 excitatory glycine receptor function. Biochem. Biophys. Res. Commun. 354 (2007) 102-108
32. Mahley R.W. Heparan sulfate proteoglycan/low density lipoprotein receptor-related protein pathway involved in type III hyperlipoproteinemia and Alzheimer's disease. Isr. J. Med. Sci. 32 (1996) 414-429
33. Mahley R.W., and Ji Z.S. Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. J. Lipid Res. 40 (1999) 1-16
34. Misra U.K., Adlakha C.L., Gawdi G., McMillian M.K., Pizzo S.V., and Laskowitz D.T. Apolipoprotein E and mimetic peptide initiate a calcium-dependent signaling response in macrophages. J. Leukoc. Biol. 70 (2001) 677-683
35. Molinoff P.B., Williams K., Pritchett D.B., and Zhong J. Molecular pharmacology of NMDA receptors: modulatory role of NR2 subunits. Prog. Brain Res. 100 (1994) 39-45
36. Morimoto K., Katayama K., Inoue K., and Sato K. Effects of competitive and noncompetitive NMDA receptor antagonists on kindling and LTP. Pharmacol. Biochem. Behav. 40 (1991) 893-899
37. Paoletti P., and Neyton J. NMDA receptor subunits: function and pharmacology. Curr. Opin. Pharmacol. 7 (2007) 39-47
38. Pittaluga A., Bonfanti A., and Raiteri M. Somatostatin potentiates NMDA receptor function via activation of InsP(3) receptors and PKC leading to removal of the Mg(2+) block without depolarization. Br. J. Pharmacol. 130 (2000) 557-566
39. Prorok M., and Castellino F.J. The molecular basis of conantokin antagonism of NMDA receptor function. Curr. Drug Targets 8 (2007) 633-642
40. Prorok M., Warder S.E., Blandl T., and Castellino F.J. Calcium binding properties of synthetic γ-carboxyglutamic acid containing marine cone snail "sleeper" peptides, conantokin-G and conantokin-T. Biochemistry 35 (1996) 16528-16534
41. Qiu Z.H., Strickland D.K., Hyman B.T., and Rebeck G.W. Alpha 2-macroglobulin exposure reduces calcium responses to N-methyl-d-aspartate via low density lipoprotein receptor-related protein in cultured hippocampal neurons. J. Biol. Chem. 277 (2002) 14458-14466
42. Saito H., Dhanasekaran P., Nguyen D., Baldwin F., Weisgraber K.H., Wehrli S., Phillips M.C., and Lund-Katz S. Characterization of the heparin binding sites in human apolipoprotein E. J. Biol. Chem. 278 (2003) 14782-14787
43. Sheng Z., Dai Q., Prorok M., and Castellino F.J. Subtype-selective antagonism of N-methyl-d-aspartate receptor ion channels by synthetic conantokin peptides. Neuropharmacology 53 (2007) 145-156
44. Sinagra M., Verrier D., Frankova D., Korwek K.M., Blahos J., Weeber E.J., Manzoni O.J., and Chavis P. Reelin, very-low-density lipoprotein receptor, and apolipoprotein E receptor 2 control somatic NMDA receptor composition during hippocampal maturation in vitro. J. Neurosci. 25 (2005) 6127-6136
45. Stouffer G.A., LaMarre J., Gonias S.L., and Owens G.K. Activated alpha 2-macroglobulin and transforming growth factor-beta 1 induce a synergistic smooth muscle cell proliferative response. J. Biol. Chem. 268 (1993) 18340-18344
46. Strickland D.K., Ashcom J.D., Williams S., Burgess W.H., Migliorini M., and Argraves W.S. Sequence identity between the alpha 2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor. J. Biol. Chem. 265 (1990) 17401-17404
47. Strittmatter W.J., Saunders A.M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G.S., and Roses A.D. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 1977-1981
48. Tacken P.J., Beer F.D., Vark L.C., Havekes L.M., Hofker M.H., and Willems Van Dijk K. Very-low-density lipoprotein binding to the apolipoprotein E receptor 2 is enhanced by lipoprotein lipase, and does not require apolipoprotein E. Biochem. J. 347 (2000) 357-361
49. Tsai M.S., Tangalos E.G., Petersen R.C., Smith G.E., Schaid D.J., Kokmen E., Ivnik R.J., and Thibodeau S.N. Apolipoprotein E: risk factor for Alzheimer disease. Am. J. Hum. Genet. 54 (1994) 643-649
50. Ulas J., and Cotman C.W. Decreased expression of N-methyl-d-aspartate receptor 1 messenger RNA in select regions of Alzheimer brain. Neuroscience 79 (1997) 973-982
51. Vicini S., Wang J.F., Li J.H., Zhu W.J., Wang Y.H., Luo J.H., Wolfe B.B., and Grayson D.R. Functional and pharmacological differences between recombinant N-methyl-d-aspartate receptors. J. Neurophysiol. 79 (1998) 555-566
52. Weisgraber K.H., Innerarity T.L., Rall S.C., and Mahley R.W. Receptor interactions controlling lipoprotein metabolism. Can. J. Biochem. Cell Biol. 63 (1985) 898-905
53. Weisgraber K.H., Rall S.C., Mahley R.W., Milne R.W., Marcel Y.L., and Sparrow J.T. Human apolipoprotein E. Determination of the heparin binding sites of apolipoprotein E3. J. Biol. Chem. 261 (1986) 2068-2076
54. Weisgraber K.H., and Xi Q. Apolipoprotein E distribution among human plasma lipoproteins: role of the cysteine-arginine interchange at residue 112. J. Lipid Res. 31 (1990) 1503-1511
55. Westein E., Denis C.V., Bouma B.N., and Lenting P.J. The alpha-chains of C4b-binding protein mediate complex formation with low density lipoprotein receptor-related protein. J. Biol. Chem. 277 (2002) 2511-2516
56. Westerlund J.A., and Weisgraber K.H. Discrete carboxyl-terminal segments of apolipoprotein E mediate lipoprotein association and protein oligomerization. J. Biol. Chem. 268 (1993) 15745-15750
57. Wetterau J.R., Aggerbeck L.P., Rall S.C., and Weisgraber K.H. Human apolipoprotein E3 in aqueous solution. I. Evidence for two structural domains. J. Biol. Chem. 263 (1988) 6240-6248
58. Wilson C., Wardell M.R., Weisgraber K.H., Mahley R.W., and Agard D.A. Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E. Science 252 (1991) 1817-1822
59. Zannis V.I., and Breslow J.L. Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and posttranslational modification. Biochemistry 20 (1981) 1033-1041
60. Zukin R.S., and Bennett M.V. Alternatively spliced isoforms of the NMDARI receptor subunit. Trends Neurosci. 18 (1995) 306-313
61. Zaiou M., Arnold K.S., Newhouse Y.M., Innerarity T.L., Weisgraber K.H., Segall M.L., Phillips M.C., and Lund-Katz S. Apolipoprotein E;-low density lipoprotein receptor interaction. Influences of basic residue and amphipathic alpha-helix organization in the ligand. J. Lipid Res. 42 (2000) 1087-1095